Takara Bio has launched a new retrovirus vector that allows for the persistent delivery of siRNAs in cells, Japan Corporate News Network said this week.
The vectors — sSINsi-hH1 DNA, pSINsi-hU6, and pSINsi-mU6 DNA — were made available on Feb. 6, JCNN added.
Select Biosciences has recently released its RNAi 2004: Strategic Opportunities market report.
The report, said Select, includes interviews with RNAi experts, evaluations of companies in the field, market models of segments of the RNAi field, and recommendations for capitalizing on various opportunities.
Details about ordering the report, along with a table of contents and sample pages, can be found at http://www.selectbiosciences.com/marketreports/rnai04.aspx.
DNA Press is publishing a new book in its Nuts & Bolts series entitled RNA Interference: The Nuts & Bolts of siRNA Technology.
The book is authored by David Engelke, a professor of biological chemistry and director in biomedical services at the University of Michigan.
Topics covered by the book include RNAi in plants, Drosophila, C. elegans, and mammals, as well as protocols for using RNAi to knock down gene expression in eukaryotes.
Following its recent acquisition of Sequitur, Invitrogen has begun directly offering Stealth RNAi oligonucleotides on its website.
Details about the oligos can now be found at http://www.invitrogen.com/content.cfm?pageid=10070.